FDA Approves Moderna’s mFlusiva, Marking a Landmark Entry for mRNA Technology into Seasonal Flu Vaccination
admin The U.S. Food and Drug Administration (FDA) has granted approval for mFlusiva, previously known as...
biotech
Braveheart Bio Spearheads Biotech IPO Surge, As Five Firms Secure Over $1 Billion in Public Offerings This Week
Braveheart Bio, a rapidly emerging biotechnology company focused on cardiovascular therapies, has successfully completed its...
Novo Nordisk Faces Setbacks as Eli Lilly’s Injectable Franchise Continues to Outperform in Fierce GLP-1 Market
The intense rivalry between pharmaceutical giants Novo Nordisk and Eli Lilly in the burgeoning market...
Attovia Therapeutics Secures $289 Million in Upsized IPO, Signifying Robust Biotech Market Recovery
Attovia Therapeutics, a burgeoning biotechnology firm focused on innovative antibody-drug technologies for skin disorders and...
Cancer Research Institute Announces 2026 Lloyd J. Old STARs: Five Visionary Scientists Poised to Transform Immunotherapy with $1.25 Million Each
The Cancer Research Institute (CRI) has proudly unveiled its 2026 class of Lloyd J. Old...
Expedition Therapeutics Secures $115 Million Series B to Advance Novel Lung Disease Therapy, Reinforcing Trend of China-Originated Drug Development
Expedition Therapeutics, a rapidly emerging biotechnology company focused on bringing innovative therapies to market, announced...
Biopharmaceutical Sector Witnesses Executive Transition at J&J, Mixed Clinical Outcomes, Strategic Alliances, and Expanded Drug Approvals
The biopharmaceutical landscape has recently been marked by a series of significant developments, including a...
Pfizer Expands Cost-Cutting Initiative to $6.5 Billion Amidst Post-Pandemic Revenue Adjustments and Pipeline Challenges
New York, NY – August 4, 2026 – Pfizer Inc. today announced a significant expansion...
Vertex Pharmaceuticals Navigates Robust Financial Growth Amidst Emerging Competitive Threats in Cystic Fibrosis Market
Vertex Pharmaceuticals, a titan in the biotechnology sector, recently reported stellar financial results for the...
Resilience and Lilly invest $750M to boost Cincinnati drug production
In a significant move to bolster the production of critical GLP-1 injectable medications, contract manufacturer...
